Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Bank of America Analyst Says
Hims & Hers Health (NYSE:HIMS – Get Free Report) had its target price increased by stock analysts at Bank of America from $21.00 to $22.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “underperform” rating on the stock. Bank of America‘s price objective would suggest a potential downside […]
More Stories
Artificial Sweeteners May Directly Affect Heart Muscle, Study Finds
By George Citroner Scientists have discovered “sweet taste” receptors in the heart that respond to artificial sweeteners like aspartame. This...
DOGE Official Says IRS Can’t ‘Perform Basic Functions’ Without Billions for Consultants
By Jack Phillips A Department of Government Efficiency (DOGE) representative said that the IRS has a number of decades-old, infrastructure-related...
Trump Says He Will Personally Cover Returned Astronauts’ Overtime Pay If NASA Doesn’t
By T.J. Muscaro NASA astronauts Butch Wilmore and Suni Williams should be paid more after their eight-day test flight of...
Trump Takes 2-Pronged Approach to Reduce Education Department
By Aaron Gifford During an Oval Office meeting earlier this year, President Donald Trump’s plans for the Department of Education...
Home Sales Jump 4.2 Percent in February: Report
By Naveen Athrappully The number of homes sold across the United States rose in February from a month earlier amid...
Enhancing Employee Experience: The Evolving Role of EOR Providers
In today’s globalised and fast-evolving workplace, businesses emphasise employee experience (EX) more intensely. Organisations that prioritise employee well-being, job satisfaction,...